1. Home
  2. ESPR vs GILT Comparison

ESPR vs GILT Comparison

Compare ESPR & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.72

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Logo Gilat Satellite Networks Ltd.

GILT

Gilat Satellite Networks Ltd.

HOLD

Current Price

$11.52

Market Cap

747.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
GILT
Founded
2008
1987
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
898.5M
747.5M
IPO Year
2013
1993

Fundamental Metrics

Financial Performance
Metric
ESPR
GILT
Price
$3.72
$11.52
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$6.86
$16.00
AVG Volume (30 Days)
6.5M
543.1K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.22
EPS
N/A
0.41
Revenue
$303,802,000.00
$392,826,000.00
Revenue This Year
$25.45
$49.48
Revenue Next Year
N/A
$13.61
P/E Ratio
N/A
$30.72
Revenue Growth
2.83
29.68
52 Week Low
$0.69
$5.30
52 Week High
$4.13
$15.24

Technical Indicators

Market Signals
Indicator
ESPR
GILT
Relative Strength Index (RSI) 56.14 42.72
Support Level $3.72 $11.91
Resistance Level $4.13 $13.08
Average True Range (ATR) 0.24 0.47
MACD -0.02 0.10
Stochastic Oscillator 23.15 14.56

Price Performance

Historical Comparison
ESPR
GILT

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

Share on Social Networks: